Literature DB >> 9701555

Aggregation of mononucleated precursors triggers cell surface expression of alphavbeta3 integrin, essential to formation of osteoclast-like multinucleated cells.

P Boissy1, I Machuca, M Pfaff, D Ficheux, P Jurdic.   

Abstract

Alphavbeta3 is a key integrin mediating adhesion of multinucleated osteoclasts during bone resorption. 1, 25-dihydroxyvitamin D3 upregulates alphavbeta3 integrin expression in mononucleated osteoclast precursors and concomitantly stimulates their differentiation into osteoclasts. This suggests that this integrin could play a major role during osteoclast differentiation. We have developed an in vitro model, in which 1, 25-dihydroxyvitamin D3 sequentially modifies the behavior of macrophages: It first induces rounding up of these cells, then their subsequent aggregation and spreading, which finally leads to cell fusion and the formation of osteoclast-like multinucleated giant cells. We show that, while 1,25-dihydroxyvitamin D3 stimulates the de novo synthesis of alphavbeta3 in macrophages early in this process, its accumulation on the surface is triggered by cell aggregation. A high level of integrin alphavbeta3 cell surface expression correlates with macrophage spreading preceding fusion. This was confirmed by means of novel cell permeable peptides containing the C-terminal sequence of the integrin beta3 tail to specifically block (alphavbeta3 function. Although this peptide has no effect on the aggregation step, it disrupts the spreading of osteoclast precursors and consequently inhibits their fusion. These findings suggest a novel role of the integrin alphavbeta3 in a discrete step of osteoclast differentiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9701555     DOI: 10.1242/jcs.111.17.2563

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  10 in total

1.  Dynamin forms a Src kinase-sensitive complex with Cbl and regulates podosomes and osteoclast activity.

Authors:  Angela Bruzzaniti; Lynn Neff; Archana Sanjay; William C Horne; Pietro De Camilli; Roland Baron
Journal:  Mol Biol Cell       Date:  2005-05-04       Impact factor: 4.138

2.  Foreign body-type multinucleated giant cells induced by interleukin-4 express select lymphocyte co-stimulatory molecules and are phenotypically distinct from osteoclasts and dendritic cells.

Authors:  Amy K McNally; James M Anderson
Journal:  Exp Mol Pathol       Date:  2011-07-23       Impact factor: 3.362

3.  Beta1 and beta2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation.

Authors:  Amy K McNally; James M Anderson
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

4.  The generation of osteoclasts from RAW 264.7 precursors in defined, serum-free conditions.

Authors:  Cristina Vincent; Masakazu Kogawa; David M Findlay; Gerald J Atkins
Journal:  J Bone Miner Metab       Date:  2008-12-05       Impact factor: 2.626

5.  Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone.

Authors:  Akihiro Yano; Shinji Tsutsumi; Shiro Soga; Min-Jung Lee; Jane Trepel; Hiroyuki Osada; Len Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-07       Impact factor: 11.205

6.  Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases.

Authors:  Jeffrey A Nemeth; Michael L Cher; Zhao Zhou; Chadwick Mullins; Sunita Bhagat; Mohit Trikha
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 7.  Molecular regulation of osteoclast activity.

Authors:  Angela Bruzzaniti; Roland Baron
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 9.306

8.  Age-related adaptation of bone-PDL-tooth complex: Rattus-Norvegicus as a model system.

Authors:  Narita L Leong; Jonathan M Hurng; Sabra I Djomehri; Stuart A Gansky; Mark I Ryder; Sunita P Ho
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

9.  Targeting αvβ3 and αvβ5 integrins inhibits pulmonary metastasis in an intratibial xenograft osteosarcoma mouse model.

Authors:  Ana Gvozdenovic; Aleksandar Boro; Daniela Meier; Beata Bode-Lesniewska; Walter Born; Roman Muff; Bruno Fuchs
Journal:  Oncotarget       Date:  2016-08-23

10.  Clinical study of 99mTc-3P-RGD2 peptide imaging in osteolytic bone metastasis.

Authors:  Guoqiang Shao; Wei Gu; Muhong Guo; Shiming Zang; Jinjing Fu; Shuang Liu; Feng Wang; Zizheng Wang
Journal:  Oncotarget       Date:  2017-04-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.